RNAi drugmaker City prices upsized IPO at $18 per share
RNAi drugmaker City prices upsized IPO at $18 per share. Market participants are assessing the implications for related sectors and asset prices. Analysts note …
Meridian Intelligence View: Meridian Intelligence view: Earnings and buybacks reflect past capital allocation. Subjective value differs by individual; markets discover prices continuously—do not equate earnings beats with lasting productivity gains.
Read full article →